Literature DB >> 1548649

Carbamazepine and folic acid in trigeminal neuralgia patients.

A A al-Musaed1, J M Zakrzewska, B J Bain.   

Abstract

The effect of carbamazepine monotherapy on the red cell folate level of 133 patients with trigeminal neuralgia was evaluated. The patient group had a significantly lower mean value of red cell folate levels compared with 110 controls. No significant correlation was found between the red cell folate levels and the mean cell volume or haemoglobin values in either the carbamazepine or control group. In addition no significant correlation was found between the red cell folate levels and drug dosage. Administration of folic acid supplements raised the mean value of red cell folate significantly. Dietary folate intake was assessed in 43 trigeminal neuralgia patients and 33 matched control patients and there was no significant difference between the groups. Patients taking carbamazepine should be advised on a well-balanced diet rich in folate as opposed to being given a routine prescription of folic acid.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1548649      PMCID: PMC1293455          DOI: 10.1177/014107689208500107

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


  14 in total

1.  SUBNORMAL SERUM FOLATE AND MACROCYTOSIS ASSOCIATED WITH ANTICONVULSANT DRUG THERAPY.

Authors:  F A KLIPSTEIN
Journal:  Blood       Date:  1964-01       Impact factor: 22.113

2.  Megaloblastic anemia associated with anticonvulsant drugs.

Authors:  J M FLEXNER; R C HARTMANN
Journal:  Am J Med       Date:  1960-03       Impact factor: 4.965

3.  Macrocytosis and macrocytic anaemia caused by anticonvulsant drugs.

Authors:  C F HAWKINS; M J MEYNELL
Journal:  Q J Med       Date:  1958-01

4.  [Hemopoietic complications of hydantoin therapy of epilepsy].

Authors:  E MANNHEIMER; F PAKESCH; E E REIMER; H VETTER
Journal:  Med Klin       Date:  1952-10-17

5.  Chronic toxicity in epileptic patients receiving single-drug treatment.

Authors:  D I Dellaportas; S D Shorvon; A W Galbraith; M Laundy; E H Reynolds; W J Marshall; I Chanarin
Journal:  Br Med J (Clin Res Ed)       Date:  1982-08-07

6.  Reinterpretation of the haematological effects of anticonvulsant treatment.

Authors:  M Rose; I Johnson
Journal:  Lancet       Date:  1978-06-24       Impact factor: 79.321

Review 7.  Anticonvulsant drugs, folic acid metabolism, fit frequency and psychiatric illness.

Authors:  E H Reynolds
Journal:  Psychiatr Neurol Neurochir       Date:  1971 Mar-Apr

8.  Antiepileptic therapy, folate deficiency, and psychiatric morbidity: a general practice survey.

Authors:  J Edeh; B K Toone
Journal:  Epilepsia       Date:  1985 Sep-Oct       Impact factor: 5.864

9.  Folate deficiency after anticonvulsant drugs: an effect of hepatic enzyme induction?

Authors:  J D Maxwell; J Hunter; D A Stewart; S Ardeman; R Williams
Journal:  Br Med J       Date:  1972-01-29

10.  A comparative study of the relative effects of anticonvulsant drugs and dietary folate on the red cell folate status of patients with epilepsy.

Authors:  T Goggin; H Gough; A Bissessar; M Crowley; M Baker; N Callaghan
Journal:  Q J Med       Date:  1987-11
View more
  2 in total

Review 1.  Epilepsy and pregnancy.

Authors:  M D O'Brien; S Gilmour-White
Journal:  BMJ       Date:  1993-08-21

2.  Comparison of tolerability and adverse symptoms in oxcarbazepine and carbamazepine in the treatment of trigeminal neuralgia and neuralgiform headaches using the Liverpool Adverse Events Profile (AEP).

Authors:  E Besi; D R Boniface; R Cregg; J M Zakrzewska
Journal:  J Headache Pain       Date:  2015-09-03       Impact factor: 7.277

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.